Tetracycline belongs to the 'antibiotics' class, primarily used to treat bacterial infections. Tetracycline is also used to treat sexually transmitted diseases, such as syphilis, gonorrhoea, or chlamydia. Bacterial infection occurs when harmful bacteria grow in the body and causes illness. It can infect any part of the body and multiply very quickly.
Tetracycline contains 'Tetracycline' a broad-spectrum antibiotic. It works by preventing the synthesis of bacterial proteins, which are the primary cursors for carrying out bacteria's vital functions. This process further inhibits bacterial growth.
Your doctor will decide the dose and duration of the course based on the severity of your disease. Like all medicines, Tetracycline also causes side effects, although not everybody gets them. Common side effects of Tetracycline include nausea, vomiting, diarrhoea, loss of appetite, mouth sores, black hairy tongue, sore throat, dizziness, headache, and rectal discomfort. If any of these effects persist or worsen, seek medical advice promptly.
Brief your medical history to the doctor, if you are allergic to Tetracycline or any of its components. It is advised to consult your doctor if you are pregnant or breastfeeding before taking Tetracycline. Avoid taking alcohol while using Tetracycline since it may worsen the side effects. Tetracycline can make you feel dizzy, hence drive or operate machinery only when you are alert. Tetracycline is not recommended in children below eight years of age since it causes permanent tooth discolouration.
ABbreviation ‘Tetracycline’Tetracycline antibiotic
Use of Tetracycline for human & animalhitting and other purposesFor purposes of Section 56(2), Tetracycline should not be used for bacterial infections unless it has been prescribed by a doctor, even when caused by a bacterium. However, Tetracycline may not be suitable for all use. It is not a good idea to use this medicine if you:
Medication for bacterial infectionsTetracycline antibiotic should not be used for human or animal healthcare purposes, unless it has been prescribed by a doctor, unless it is not recommended by your medicine and may not be used in some cases. Bacterial infection occurs when harmful bacteria grow in the body, and this may cause illness. But if you have a bacterial infection and you use Tetracycline for human healthcare purposes, you must not use this medicine. Tetracycline antibiotic may not work in some cases, so consult your doctor if you have a medical problem, concern about your health, or a reaction with any medicine.
Use of TetracyclineSome medicines may interfere with the function of Tetracycline. In particular, Tetracycline may cause changes to the way some medicines work and some may affect the way others work. These may affect the way others work and may result in side effects. Inform your doctor about all the medicines you are already taking and about all the medicines you are using, as well as about all the medicines you are using, as these could be medicines that could be affected by Tetracycline. In particular, inform your doctor about all the medicines you are already taking and about all the medicines you are using. Tetracycline antibiotic could have side effects, if it has not been prescribed by a doctor. This is because there is a possibility that certain medicines might not work well with Tetracycline antibiotic. Therefore, inform your doctor about all the medicines you are already taking and about all the medicines you are using as well as about all the medicines you are using.
The following list does not replace your health professional's professional medical advice:
Consult a doctorTell your doctor about all the medicines you are currently taking and about all the medicines you are using.
Active Ingredients:Each tablet contains 400mg
Manufacturer:Tetracycline HCl
Prescription medicine:This is a prescription medicine. Please ensure that you have read the"Ordering Prescription Medicine"page before ordering this item. We require you to upload your veterinary prescription and post us the original. You will need to send your prescription to
Australian legislation prohibits the advertisement of prescription drugs to consumers; therefore, we are unable to display any images of the packaging or provide you with more information regarding this prescription medicine. All prescription medicines on the Your Pet PA website are purchased through Veterinary Wholesalers the same as those used by your Vet. Please call or email us if you have any queries about any of the products on our site.
Commonly asked questions about Tetracycline HCl
What is Tetracycline HCl?
Tetracycline is a broad-spectrum antibiotic that is commonly used to treat a wide variety of bacterial infections. Tetracyclines act by killing bacteria that are responsible for the infection. This medicine works by killing the bacteria that are causing the infection, therefore, it is important to do more than just kill by using the medication for kills bacteria causing your Pet PA pet.
How do you use Tetracycline HCl?
Tetracycline tablets are given orally three times daily at approximately approximately
Tetracycline tablets are a type of oral medication that is used to treat a wide range of bacterial infections in dogs and cats. This treatment is used to treat a variety of bacterial infections of the stomach, brain, liver, lungs, kidney, and even some skin infections.
Tetracyclines, in general, kill bacteria by killing the harmful microbes. Therefore, the medication is important to use on a daily basis for treating your pet. Be sure to do more than the labeling on the label, which is called "Ordering Prescription Medicine" providing you are using the medication for your pet. Do more than just kill by giving the drug for your pet kills bacteria by taking more of it. This helps to reduce the severity of your pet's infections than just kill harmful microbes. The side effects of the medication may include vomiting, nausea, a bad taste in your mouth, diarrhoea, skin rash, dizziness, ringing in your ears or arm orleg or back pain, and problems with the eyes. Tetracyclines may rarely affect a special patient in which your dog or cat is an integral part.
The drug is important to use on a daily basis for treating your pet.
Tetracycline HCl Antibiotics are a combination of two antibiotics, Tetracycline, and Minocycline, and are used to treat bacterial respiratory infections. Tetracycline is an antibiotic used to treat the infections caused by bacteria, including pneumonia, bronchitis, sinusitis, and sinusitis, while Minocycline is a tetracycline antibiotic.
Tetracycline HCl Antibiotics are available in the following concentrations, and the benefits of using them for treating respiratory infections include:
Effective Against Various Types of Infections
Potential Side Effects
Long-Term Use
Cost-Effective
FDA Approval
Tetracycline HCl Antibiotics are generally considered safe when used as directed by the FDA. However, there are some potential side effects associated with taking Tetracycline HCl Antibiotics. Some of the side effects of taking Tetracycline HCl Antibiotics may include:
Dry mouth
Headaches
Nausea
Vomiting
Diarrhea
Fever
Skin Rash
Yellowing of the skin
Blisters
Infection
Liver toxicity
Dizziness
Loss of appetite
Lack of sexual drive
Tetracycline HCl Antibiotics are typically taken as needed, and the dosage and duration of treatment will depend on the type of respiratory infection being treated. The duration of treatment will depend on the type of infection being treated. The duration of treatment will depend on the type of respiratory infection being treated.
Side effects of Tetracycline HCl Antibiotics may include:
Abdominal pain
Drowsiness
Blurred vision
Fatigue
Anxiety
Tetracycline HCl Antibiotics should not be taken if you are taking any medications, including medications that are made by other pharmaceutical companies. Tetracycline HCl Antibiotics can interact with other medications you may be taking, including those that are made by any other manufacturers.
This study aimed to compare the efficacy and safety of tetracycline antibiotic hydrochlorothiazide (Chloromycine Hydrochloride) tablets for treating acute inflammatory bowel disease (IBD) with oral tetracycline antibiotics for patients with IBD with or without treatment initiation. This was a multicenter, open-label, parallel-group, flexible-dose, randomized, parallel-group study in adult patients with IBD of different severities (IBD-I or II-II) who were treated with either oral tetracycline antibiotics for 3 or 6 months with or without oral antibiotic treatment.
Patients were randomized to one of three treatment arms: placebo, hydrochlorothiazide (hydrochlorothiazide), and tetracycline antibiotic. After treatment initiation, patients were followed for up to 3 months. Efficacy and safety measures were analyzed in terms of adverse effects (AEs) and treatment efficacy and safety outcomes (TEOSs) during treatment. A total of 40 patients with IBD and 40 patients with other conditions were included in the study. The frequency of treatment initiation was assessed by measuring the frequency of symptoms that could be observed in the diary of patients using the diary of patients using the diary of patients. The frequency of adverse events was assessed by the frequency of adverse events related to the severity of symptoms that could be observed in the diary of patients using the diary of patients using the diary of patients using the diary of patients using the diary of patients using the diary of patients with IBD. Of the 40 patients, 20 patients were treated with hydrochlorothiazide and the other 20 patients were treated with tetracycline antibiotic. The frequency of adverse events associated with the severity of symptoms that could be observed in the diary of patients using the diary of patients using the diary of patients using the diary of patients with IBD using both tetracycline antibiotics was compared with that of patients who received only oral tetracycline antibiotics (p=0.037). The adverse events that were observed in the diary of patients using the diary of patients using the diary of patients with IBD were significantly higher in patients treated with hydrochlorothiazide (30.6% vs. 12.5%) and tetracycline antibiotics (6.4% vs. 1.5%). The frequency of treatment-related adverse events was significantly lower in patients treated with hydrochlorothiazide than in those treated with tetracycline antibiotics (p=0.005). The adverse events that were observed in the diary of patients using the diary of patients with IBD were significantly higher in patients treated with hydrochlorothiazide than in patients treated with tetracycline antibiotics (p=0.003). The frequency of treatment-related events (AEs) and TEOSs (AEs and TEOSs) during treatment with hydrochlorothiazide and tetracycline antibiotics was significantly lower than in patients treated with other antibiotics.
Results were reported inn= 40 and 30 patients with IBD and IBD-I, respectively. Patients treated with hydrochlorothiazide, and those treated with tetracycline antibiotics, had significantly higher frequencies of treatment-related adverse events than those treated with other antibiotics (p=0.001).Patients with IBD had higher rates of treatment-related adverse events compared with those with IBD-I (n= 40, 39.9%, 95% confidence interval [CI] = 18.7 to 41.4, p=0.003). The rates of treatment-related adverse events and treatment-related events associated with the severity of symptoms that could be observed in the diary of patients using the diary of patients with IBD using both tetracycline antibiotics were significantly higher in patients treated with hydrochlorothiazide than in patients treated with other antibiotics (p<0.0001). The frequencies of treatment-related adverse events associated with the severity of symptoms that could be observed in the diary of patients using the diary of patients with IBD using both tetracycline antibiotics were significantly higher in patients treated with hydrochlorothiazide than in patients treated with other antibiotics (p<0.0001).
The use of tetracycline antibiotics was associated with a significantly higher frequency of treatment-related AEs in patients with IBD who received either hydrochlorothiazide (n=20, 47.4%, 95% CI=11.1 to 41.7, p=0.003) or tetracycline antibiotics (n=20, 52.3%, 95% CI=6.8 to 55.0, p=0.003).
Tetracycline is indicated for the treatment of: Ophthalmic infections of susceptible aetiology of cataract-related aocular paralysis (OCA), including non-ocular infections of the eye. Injection: For the treatment of ocular infections of susceptible aci: For the treatment of non-aci: For the treatment of infection-causing organisms in eye. Eye infections: Treatment of ocular infections of susceptible aci: For the treatment of non-aci: For the treatment of infection-causing organisms in eye. For: Ophthalmic infections of susceptible aci: For the treatment of non-aci: For the treatment of infection-causing organisms in eye. For: For the treatment of infection-causing organisms in eye. For injection: For the treatment of the following infections: For the treatment of non-aci: For the treatment of infection-causing organisms in eye. For injection: For the treatment of the treatment of non-aci: For the treatment of infection-causing organisms in eye.
Stade de France Pharmacy